Related Experiment Video
Updated: Mar 9, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Statin Therapy as Primary Prevention in Exercising Adults: Best Evidence for Avoiding Myalgia
1From the Department of Family Practice, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
Active adults on statins who experience muscle pain (myalgia) may reduce exercise. Strategies exist to manage statin myopathy, but exercise alone can offer comparable cardiovascular benefits and superior mortality reduction.
Area of Science:
- Exercise Physiology
- Pharmacology
- Cardiology
Background:
- Statins are commonly prescribed cholesterol-lowering medications.
- Exercise is crucial for cardiovascular health.
- Statin-induced myopathy can affect physically active individuals.
Purpose of the Study:
- To investigate if active adults reduce physical activity due to statin-induced myalgia.
- To explore strategies for mitigating statin myopathy symptoms in exercisers.
- To assess exercise as an alternative to statin therapy if symptoms persist.
Main Methods:
- Literature search of PubMed, Google Scholar, and Cochrane Database.
- Keywords focused on statin myopathy in exercising adults.
- Review of evidence on symptom management and exercise alternatives.
Main Results:
- Most exercising adults tolerate statins well; caution advised for high-level exercisers, elderly, and high-dose users.
- Low-quality evidence suggests strategies to improve statin tolerance and maintain exercise.
- Exercise programs can offer equivalent or superior cardiometabolic protection if statins are not tolerated.
Conclusions:
- Statins can impede physical activity, but myopathy risk can be reduced.
- Exercise provides significant cardiovascular protection and mortality benefits, with improved quality of life.
- When necessary, exercise is a viable alternative to statin therapy for cardiovascular health.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Angina IV: Management
Coronary Artery Disease IV: Preventive Measures
Skeletal Muscle Relaxants: Therapeutic Uses
